Drugs / ICA-105665
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00962663 | Aug → Dec 2009 | — | Pfizer | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00979004 | Sep 2009 → Sep 2010 | epilepsy | Pfizer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ICA-105665 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00962663 ↗ |
| Route | Oral | “Oral tablet.” NCT00979004 ↗ |